Clinical trial for Obsessive - Compulsive Disorder
Official title SONATA Dose Duration LIFU for OCD
ClinicalTrials.gov ID: NCT07887633
What this study is testing
- What it's testing
- The study is checking if the ultrasound is safe, well tolerated, and reaches the target brain area.
- Who it's for
- Adults who have been diagnosed with obsessive‑compulsive disorder.
- What's involved
- Participants will wear a device that delivers focused ultrasound to a specific brain region during scheduled visits.
- Phase 2: a mid-size study of how well it works
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 80
You may be able to join if
- Age 22-80
- Meet DSM-V criteria for OCD ≥ 1 year with a Y-BOCS score ≥ 16
- Must be on the same stable dose(s) of OCD medication for at least 4 weeks prior to screening and throughout the course of the study
You likely can't join if
- Co-morbid psychiatric disorder other than depression or anxiety disorder
- Active suicidal risk (defined by C-SSRS)
- History of neurological condition
- Pregnant or breastfeeding, or planning to become pregnant during the study period
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.